Similarly, high expression levels of CASC15 [175], CYTOR (also known as Linc00152) [174], HANR [176], ICR (ICAM-1-Related ncRNA) [177], linc-UFC1 [166], lncRNA-ATB [170], lncSHRG [178], MVIH [179], PANDAR [180], PCAT14 [181], SNHG6 [182], SNHG20 [183], TINCR [184], TMCC1-AS1 [72], UBE2CP3 [185], WRAP53 [116]], ZEB1-AS1 [186], as well as the downregulation of LOC728290 [187], GAS5 [188], DILC [189], or WT1-AS [190], have been variably shown to be correlated with clinical severity, aggressive pathological features, metastasis, and/or poor outcome in HCC patients (Table S1). This evidence concerns the gene UFC1 and hepatocellular carcinoma.